AT&T (T) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
https://www.zacks.com/stock/news/2258355/at-t-t-q1-earnings-on-the-horizon-analysts-insights-on-key-performance-measures?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2258355
Apr 19, 2024 - Beyond analysts' top -and-bottom-line estimates for AT&T (T), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
0
AT&T (T) vs. T-Mobile (TMUS): Which Stock Wins in Q1 Earnings?
https://www.zacks.com/stock/news/2260540/at-t-t-vs-t-mobile-tmus-which-stock-wins-in-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2260540
Apr 23, 2024 - TMUS appears to be a better pick now compared to T, given the solid EPS growth in recent quarters, greater 5G coverage and robust demand for postpaid services.
0
Top Research Reports for Abbott, T-Mobile & Booking
https://www.zacks.com/commentary/2219543/top-research-reports-for-abbott-t-mobile-booking?cid=CS-ZC-FT-research_daily-2219543
Feb 01, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), T-Mobile US, Inc. (TMUS) Booking Holdings Inc. (BKNG).
0
T. Rowe Price (TROW) to Post Q4 Earnings: What's in the Cards?
https://www.zacks.com/stock/news/2219670/t-rowe-price-trow-to-post-q4-earnings-what-s-in-the-cards?cid=CS-ZC-FT-analyst_blog|earnings_preview-2219670
Feb 01, 2024 - T. Rowe Price (TROW) is expected to have witnessed an improvement in AUM in the fourth quarter of 2023 due to favourable equity market performance partially offset by net outflows.
0
T. Rowe Price (TROW) Expected to Beat Earnings Estimates: Should You Buy?
https://www.zacks.com/stock/news/2219608/t-rowe-price-trow-expected-to-beat-earnings-estimates-should-you-buy?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2219608
Feb 01, 2024 - T. Rowe (TROW) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
0
Samsung C&T investors pushing for dividend, share buybacks
https://seekingalpha.com/news/4062217-samsung-ct-investors-pushing-for-dividends-share-buybacks?source=feed_sector_healthcare
Feb 02, 2024 - Investors urge Samsung to increase dividends and begin share repurchase plan.
0
Want to Gain $1,000 in Annual Dividend Income? Invest $11,900 in These 3 High-Yield Dividend Stocks.
https://www.fool.com/investing/2024/02/04/want-to-gain-1000-in-annual-dividend-income-invest/?source=iedfolrf0000001
Feb 04, 2024 - Building up a passive income stream could be easier than you expect.
0
Bristol Myers (BMY), TSVT CAR T-Cell Therapy to Face FDA's ODAC
https://www.zacks.com/stock/news/2221922/bristol-myers-bmy-tsvt-car-t-cell-therapy-to-face-fda-s-odac?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2221922
Feb 06, 2024 - Bristol Myers (BMY) and its partner TSVT announce that the FDA's ODAC will meet in March to review data supporting the label expansion for CAR T-cell therapy.
0
T. Rowe Price (TROW) Q4 Earnings Beat Estimates, AUM Rises Y/Y
https://www.zacks.com/stock/news/2223559/t-rowe-price-trow-q4-earnings-beat-estimates-aum-rises-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-2223559
Feb 08, 2024 - T. Rowe Price's (TROW) Q4 earnings beat estimates on increased net revenues, an improvement in AUM and a decline in expenses. A rise in cash and cash equivalents will help it continue investing.
0
3 Cheap Tech Stocks to Buy Right Now
https://www.fool.com/investing/2024/02/12/3-cheap-tech-stocks-to-buy-right-now/?source=iedfolrf0000001
Feb 12, 2024 - IBM, AT&T, and Cisco are all attractive safe haven plays.
0